Related Experiment Videos
Endothelial dysfunction in diabetes mellitus
S Schiekofer1, B Balletshofer, M Andrassy
1Department of Medicine IV, University of Tübingen, Germany. stephan.schiekofer@med.uni-tuebingen.de
Insights
Diabetes and prediabetes cause endothelial dysfunction, increasing cardiovascular risks. Impaired blood vessel function, not just high blood sugar, contributes to serious complications.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Vascular Biology
Background:
- Diabetes mellitus and impaired glucose tolerance are significant risk factors for cardiovascular morbidity and mortality.
- Vascular disease in diabetes is linked to plasma glucose levels, but other factors like hypertension, hyperlipidemia, and genetics also play crucial roles.
- Endothelial dysfunction is a primary driver of cardiovascular disease in diabetic patients.
Purpose of the Study:
- To explore the multifaceted mechanisms of endothelial dysfunction in diabetes.
- To understand how hyperglycemia and other risk factors contribute to vascular complications.
- To highlight the complexity of diabetic vascular disease and the limitations of single therapeutic approaches.
Main Methods:
- Review of existing literature on diabetes, endothelial function, and cardiovascular disease.
- Analysis of the roles of hyperglycemia, endothelin-1, nitric oxide (NO), and advanced glycosylated end products (AGEs).
- Examination of factors influencing vascular tone, coagulation, cell-cell interaction, and vascular permeability in diabetic models.
Main Results:
- Elevated endothelin-1 levels in diabetics contribute to vasoconstriction and are directly related to plasma glucose.
- The endothelial cell-Nitric Oxide (NO) axis is impaired, with reduced NO release and function, exacerbating vasoconstriction.
- Hyperglycemia, genetic factors, reactive oxygen species, and AGEs contribute to impaired endothelial relaxation and increased vascular permeability.
Conclusions:
- Diabetic vascular complications arise from complex endothelial dysfunction involving multiple pathways.
- Impaired endothelial function, including vasoconstriction and increased permeability, is central to diabetic cardiovascular disease.
- A single therapeutic strategy is unlikely to address the diverse vascular complications associated with diabetes and prediabetes.
Abstract:
Diabetes mellitus and impaired glucose tolerance are linked to increased cardiovascular morbidity and mortality. Vascular disease is directly associated with plasma glucose levels, and reduction of these levels forestalls to a certain extent the vascular complications of diabetes, such as myocardial infarction, nephropathies, and retinopathies. In addition to hyperglycemia, there are other risk factors that play a prominent role, such as hypertension, hyperlipidemia, and genetic factors. Endothelial dysfunction is one of the major factors in the development of cardiovascular disease. The vascular endothelium regulates the blood flow by tightly controlling the coagulation system, cell-cell interaction, and vascular tone. These functions are disturbed in diabetic patients. In diabetics, endothelin-1 levels are increased, leading to vasoconstriction. Endothelin levels are directly related to plasma glucose levels. In addition, the endothelial cell-NO axis is disturbed. NO release and function are impaired. This seems to be dependent upon hyperglycemia and genetic factors. Impaired NO function also results in vasoconstriction. Furthermore, enhanced vascular permeability is seen in diabetics. This appears to be related to impaired endothelial cell relaxation and reactive oxygen species as well as advanced glycosylated end products (AGEs). The complex changes seen in diabetes and even prediabetes are therefore related to numerous derailments related to endothelial dysfunction, and no single therapeutic approach is likely to solve the problem of vascular complications.